Back
Day Range
$3.10
$3.25
52-Week Range
$1.26
$6.55
Volume
1,343,781
50D / 200D Avg
$4.05
/
$3.93
Prev Close
$3.11
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.4 | 0.4 |
| P/B | 5.2 | 2.9 |
| ROE % | -118.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.5 | 0.2 |
Key Takeaways
Debt/Equity of 0.49 — conservative balance sheet
Negative free cash flow of -144.77M
PEG of 0.24 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-118.70%
ROIC-59.74%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.49
Current Ratio1.89
Interest Coverage0.00
Valuation
P/E Ratio
-3.41
P/B Ratio5.18
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -244.17M |
| ROE | -118.70% | ROA | -58.57% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -144.77M |
| ROIC | -59.74% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.49 | Current Ratio | 1.89 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.41 | P/B Ratio | 5.18 |
| P/S Ratio | N/A | PEG Ratio | 0.24 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 832.62M | Enterprise Value | 839.62M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -244.17M | -266.76M | -283.26M | -269.48M | -355.93M |
| EPS (Diluted) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 |
| Gross Profit | -12.75M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -190.96M | -272.72M | -293.14M | -272.56M | -356.91M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 416.89M | 501.02M | 565.30M | 822.72M | 1.13B |
| Total Liabilities | 256.01M | 250.52M | 277.79M | 323.41M | 400.91M |
| Shareholders' Equity | 160.88M | 250.50M | 287.51M | 499.32M | 728.50M |
| Total Debt | 78.86M | 94.20M | 104.10M | 108.25M | 110.94M |
| Cash & Equivalents | 71.87M | 127.57M | 133.52M | 176.77M | 253.03M |
| Current Assets | 148.68M | 160.81M | 213.52M | 444.44M | 558.10M |
| Current Liabilities | 78.73M | 45.43M | 64.49M | 111.50M | 99.24M |